Intralipid Decreases Apolipoprotein M Levels and Insulin Sensitivity in Rats

Abstract

These results suggest that Intralipid could decrease hepatic ApoM levels. ApoM overexpression may have a potential role in improving insulin resistance in vivo and modulating apoM expression might be a future therapeutic strategy against insulin resistance in type 2 diabetes.